Clinical Trials Browser

Phase 1 × Solid Tumors Harboring NTRK Fusion × Solutions × Clear all

NCT04771390 2021-08-25

Study to Compare How the Body Absorbs, Distributes and Excretes the Drug Selitrectinib (BAY2731954) Given as Two Different Tablet Formulations or as Liquid Formulations Including the Effect of Food on the Absorption, Distribution or Excretion of the Different Formulations in Healthy Participants

Phase 1 Completed

Other solid neoplasm

Solid Tumors Harboring NTRK Fusion